dc.contributor.advisor | Sharmin, Sabrina | |
dc.contributor.author | Nayon, MD.Khalid Mahmud | |
dc.date.accessioned | 2024-06-06T08:56:13Z | |
dc.date.available | 2024-06-06T08:56:13Z | |
dc.date.copyright | ©2022 | |
dc.date.issued | 2022-11 | |
dc.identifier.other | ID 17346034 | |
dc.identifier.uri | http://hdl.handle.net/10361/23213 | |
dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022. | en_US |
dc.description | Cataloged from the PDF version of the thesis. | |
dc.description | Includes bibliographical references (pages 44-53). | |
dc.description.abstract | The ability to treat sickness is continually evolving. In this field, various approaches are being used. One of the deadliest diseases for which there are now no better treatments is cancer. There is a lot of utilization of conventional techniques such as chemotherapy, radiation, targeted therapy, and immunotherapy. However, they have detrimental side effects from which there is little chance of recovery. like cytotoxicity, specificity, drug resistance to multiple drugs, and so on. However, harsh treatment is now carried out in a laboratory setting. Such as nanotechnology. Different nanoparticles are employed in this technology to transport medications to the body's diseased areas to maximize therapeutic impact while reducing negative effects. Because of their unique benefits, Nanoparticles which are1-100 nm in size, can be utilized to treat cancer because of their better permeability, decreased toxicity, increased remarkable stability, biocompatibility, retention impact, and precision targeting. These particles make use of both the tumor's properties and its surrounding environment. These nanoparticle therapies help not just with cancer therapy but also with drug resistance to many medications. To lessen toxicity, increase permeability, lessen the effect of shielding, boost the retention effect, and other effects, numerous studies have already been conducted or are now being conducted. Many more studies are required to produce the best results. This review's objective is to inform readers about recent developments in cancer treatment using nanotechnology. | en_US |
dc.description.statementofresponsibility | MD.Khalid Mahmud Nayon | |
dc.format.extent | 72 pages | |
dc.language.iso | en | en_US |
dc.publisher | BRAC University | en_US |
dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
dc.subject | Nanoparticles | en_US |
dc.subject | Cellular targeting | en_US |
dc.subject | Multidrug resistance | en_US |
dc.subject | Cryosurgery | en_US |
dc.subject | Tumor microenvironment | en_US |
dc.subject | Blood-brain barrier | en_US |
dc.subject | Drug delivery | en_US |
dc.subject | Protein corona | en_US |
dc.subject.lcsh | Proteins | |
dc.subject.lcsh | Cancer cells | |
dc.subject.lcsh | Carcinogenesis | |
dc.title | Nanotechnology advancement in the field of curing cancer | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | School of Pharmacy, Brac University | |
dc.description.degree | B. Pharmacy | |